Inactive Instrument
Raptor Pharmaceutical Corp Stock
Stocks
US75382F1066
Biotechnology & Medical Research
|
End-of-day quote
Other stock markets
|
||
| - USD | - |
|
| Manager | Title | Age | Since |
|---|---|---|---|
Paul Hoelscher
DFI | Director of Finance/CFO | 61 | 25/10/2016 |
| Corporate Officer/Principal | 64 | 01/01/2014 |
| Director | Title | Age | Since |
|---|---|---|---|
Paul Hoelscher
BRD | Director/Board Member | 61 | 25/10/2016 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.13% | -1.33% | +67.18% | +121.93% | 55.63B | |
| +6.76% | +22.83% | +91.66% | +101.42% | 52.25B | |
| +2.22% | +3.75% | -12.11% | -12.55% | 23.07B | |
| +0.46% | +5.41% | +3.28% | +411.52% | 22.41B | |
| +6.78% | +14.47% | +40.28% | -6.67% | 17.32B | |
| +0.97% | +3.81% | +30.68% | -32.21% | 15.94B | |
| -0.66% | +6.06% | +23.56% | +187.24% | 13.77B | |
| +9.96% | +19.81% | +157.65% | +320.70% | 13.47B | |
| +4.21% | +4.76% | +33.21% | - | 12.43B | |
| Average | +3.44% | +6.84% | +48.38% | +136.42% | 25.14B | |
| Weighted average by Cap. | +3.25% | +7.62% | +54.65% | +127.57% |
- Stock Market
- Stocks
- Stock
Select your edition
All financial news and data tailored to specific country editions
